1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Clinical phenotype and course of PDE6A-associated retinitis pigmentosa disease, characterized in preparation for a gene supplementation trial
(
- Contribution to journal › Article
- 2018
-
Mark
Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(13). p.2997-3006(
- Contribution to journal › Article